![]() |
![]() |
![]() |
||||
![]() |
||||||
![]() |
![]() |
![]() |
||||
![]() |
![]() |
![]() |
||||
![]() |
Preventing the maturation or intracellular trafficking of tyrosinase is an alternative way to reduce the effect of the enzyme on pigmentation. Various natural extracts can also influence tyrosinase mRNA at the transcription level; also mRNA of the other tyrosinase-related proteins or microphtalmia transcription factor (MITF) can be affected. The protease activated receptor 2 (PAR-2) is important for melanosomal transfer from melanocytes to keratinocytes and that this transfer can be used as a target for skin lightening. Regulation of cutaneous pigmentation is dependent on several processes beyond melanin synthesis within the melanosome. The efficiency of melanosomal transfer from melanocytes to keratinocytes, followed by melanosome processing in the recipient keratinocytes plays a critical role in skin pigmentation. Without successful transfer of melanosomes to keratinocytes, the skin can appear essentially unpigmented. Treatment modalities aimed at inhibiting melanosome transfer may influence and modulate skin pigmentation.
|
> > > >
|
TYROSINASE INHIBITORS Polyphenols Benzaldehyde and Benzoate Derivatives Gallic Acid and Derivatives Long-Chain Lipids and Steroids INHIBITORS OF MELANOSOMAL TRANSFER ANTIOXIDANTS ACCELERATORS OF EPIDERMAL TURNOVER AND DESQUAMATORS TRANSCRIPTIONAL REGULATION OF MELANOGENIC ENZYMES |
![]() |
||
<< Previous: Long_Chain Lipids and Steroids |
Next: Centaureidin and Methylophiopogonanone B >> |
|||||
Skin Whitening Science © 2012 | |